Eskens, F. A. L. M., Tresca, P., Tosi, D., Van Doorn, L., Fontaine, H., Van der Gaast, A., . . . Dieras, V. (2014). A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours. Nature Publishing Group.
Chicago Style CitationEskens, F A L M., et al. A Phase I Pharmacokinetic Study of the Vascular Disrupting Agent Ombrabulin (AVE8062) and Docetaxel in Advanced Solid Tumours. Nature Publishing Group, 2014.
Cita MLAEskens, F A L M., et al. A Phase I Pharmacokinetic Study of the Vascular Disrupting Agent Ombrabulin (AVE8062) and Docetaxel in Advanced Solid Tumours. Nature Publishing Group, 2014.
Atenció: Aquestes cites poden no estar 100% correctes.